Centessa Pharmaceuticals plc (LON:0ACX)
London · Delayed Price · Currency is GBP · Price in USD 28.87
-1.57 (-5.15%)
At close: Mar 27, 2026
Centessa Pharmaceuticals Market Cap
Centessa Pharmaceuticals has a market cap or net worth of 3.15 billion as of March 27, 2026. Its market cap has increased by 83.61% in one year.
Market Cap
3.15B
Enterprise Value
3.06B
Revenue
11.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.87
Market Cap Chart
Since May 28, 2021, Centessa Pharmaceuticals's market cap has increased from 1.34B to 3.15B, an increase of 135.29%. That is a compound annual growth rate of 19.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 3.15B | 16.22% |
| Dec 31, 2025 | 2.71B | 53.88% |
| Dec 31, 2024 | 1.76B | 189.13% |
| Dec 29, 2023 | 610.11M | 150.68% |
| Dec 30, 2022 | 243.38M | -67.44% |
| Dec 31, 2021 | 747.59M | -44.24% |
| May 28, 2021 | 1.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Persimmon | 3.45B |
| British Land Company | 3.43B |
| Aberdeen Group | 3.35B |
| JD Sports Fashion | 3.32B |
| The Berkeley Group Holdings | 3.22B |
| Johnson Matthey | 3.16B |
| Rightmove | 3.12B |
| Taylor Wimpey | 3.06B |